Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-01-04
2005-01-04
Romeo, David (Department: 1647)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S014800, C530S326000, C530S327000
Reexamination Certificate
active
06838438
ABSTRACT:
The present invention is directed to polynucleotides, polypeptides and peptide fragments thereof, and uses thereof for a novel cDNA sequence which has homology to motilin. Tissue distribution of the mRNA for the novel polypeptide is specific to the stomach, small intestine and pancreas. The present invention further includes agonists, antagonists, antibodies, host cells expressing the cDNA encoding the novel motilin homologs and methods for increasing gastric motility using the novel molecules.
REFERENCES:
patent: 3978035 (1976-08-01), Wunsch et al.
patent: 5006469 (1991-04-01), Adelman et al.
patent: 5470830 (1995-11-01), Macielag et al.
patent: 6380158 (2002-04-01), Sheppard
patent: 6420521 (2002-07-01), Sheppard et al.
patent: 6627729 (2003-09-01), Sheppard et al.
Bowie et al. Deciphering the message in protein sequences: tolerance to amino acid substitutions. Science, (Mar. 16, 1990) 247 (4948) 1306-10.*
Ngo et al., in The Protein Folding Problem and Tertiary Structure Prediction, Merz and Le Grand (Eds), Aug. 1994, Springer Verlag, pp. 433 and 492-495.*
Immunology: A Short Course, by Eli Benjamini, Sidney Leskowitz (Editor), Wiley-Liss, Inc., New York, NY., Jul. 1991, p. 40.*
Bennett et al. Correspondence between a mammalian spliceosome component and an essential yeast splicing factor. Science. Oct. 1, 1993;262(5130): 105-8.*
LIFESEQ™ Clone Information Results, Incyte Pharmaceuticals Inc., year unknown.
LIFESEQ™ Clone Information Results, Incyte Pharmaceuticals Inc., year unknown.
LIFESEQ™ Clone Information Results, Incyte Pharmaceuticals Inc., 1997.
LIFESEQ™ Clone Information Results, Incyte Pharmaceuticals Inc., 1997.
LIFESEQ™ Clone Information Results, Incyte Pharmaceuticals Inc., 1997.
LIFESEQ™ Library Information Results, Incyte Pharmaceuticals Inc., 1997.
LIFESEQ™ Library Information Results, Incyte Pharmaceuticals Inc., 1997.
Pearson et al.,Gastrointestinal Hormones in Medicine22: 753-774, 1993.
Dalkh et al.,DNA8: 615-621, 1989.
LIFESEQ™ Clone Information Results, Incyte Pharmaceuticals Inc., 1996.
LIFESEQ™ Clone Information Results, Incyte Pharmaceuticals Inc., 1996.
LIFESEQ™ Clone Information Results, Incyte Pharmaceuticals Inc., 1996.
LIFESEQ™ Clone Information Results, Incyte Pharmaceuticals Inc., 1996.
LIFESEQ™ Clone Information Results, Incyte Pharmaceuticals Inc., 1996.
LIFESEQ™ Clone Information Results, Incyte Pharmaceuticals Inc., 1996.
LIFESEQ™ Electronic Northern Results, Incyte Pharmaceuticals Inc., 1996.
LIFESEQ™ Library Information Results, Incyte Pharmaceuticals Inc., 1996.
LIFESEQ™ Library Information Results, Incyte Pharmaceuticals Inc., 1996.
LIFESEQ™ Library Information Results, Incyte Pharmaceuticals Inc., 1996.
LIFESEQ™ Library Information Results, Incyte Pharmaceuticals Inc., 1996.
Strausberg. Cancer Genome Anatomy Project, 1997.
LIFSEQ™ Clone Information Results, Incyte Pharmaceuticals Inc., year unknown.
U.S. patent application Ser. No. 09/796,158, Sheppard et al., filed Feb. 27, 2001.
U.S. patent application Ser. No. 09/853,253, Jaspers et al., filed May 10, 2001.
U.S. patent application Ser. No. 10/186,414, Sheppard et al., filed Jun. 30, 2001.
U.S. patent application Ser. No. 09/718,803, Sheppard et al., filed Nov. 22, 2001.
Feighner, S. et al.,Science 284: 2184-2188, Jun. 25, 1999.
Miller, P. et al.Peptides 16: 11-18, 1995.
Peeters, T. et al.,Peptides 13: 1103-1107, 1992.
Ngo, J. et al., “The Protein Folding Problem and Tertiary Structure Prediction”, Merz and Le Grand (Eds) Springer Verlag, 433, 492-495, (1994).
Kai, Y. et al.,Chem. Pharm. Bull. (Tokoyo) 10: 2346-2352 (1975).
Sekal, T. et al.,Regul. Pept. 53: 249-257, 1994.
Bormans, V. et al.,Regul. Pept 15: 143-153, 1986..
Hasler, W. et al.,Am. J. Physiol. 262(1 Pt1)G 50-65, 1992.
Depoortere, I. et al.,Peptides 12: 89-94, 1991.
Koutsoviti-Papadopoulou, M. et al., Gen. Pharmac. 25(1): 93-95, 1994.
Bishop Paul D.
Deisher Theresa A.
Jaspers Stephen R.
Labroo Virender M.
Sheppard Paul O.
Adams Robyn
ZymoGenetics Inc.
LandOfFree
Motilin Homologs does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Motilin Homologs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Motilin Homologs will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3420967